🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Maraviroc (MVC) is a type of HIV medicine called a CCR5 inhibitor. This stu...
Status
Completed
Location
UAB HIVTR-CCR5 Non-Network CRS
Start Date
2017-01-01
Trial ID
NCT02741323
Rapid and rational health-care interventions are of great importance to eff...
Status
Terminated
Location
University hospital Hamburg Eppendorf
Start Date
2014-01
Trial ID
NCT01931592
Treatments Being Tested
The hypothesis is that Sirolimus, (Rapamycin (R)) which is currently used i...
Status
Active Not Recruiting
Location
University of Kansas Medical Center
Start Date
2022-07-01
Trial ID
NCT04789070
The goal of this clinical trial is to investigate the immunomodulatory effe...
Status
Recruiting
Location
Intensive Care Medicine, Radboud University Nijmegen Medical Centre
Start Date
2024-10-24
Trial ID
NCT06624436
Treatments Being Tested
To determine if conversion to enteric coated MPA allows an escalated dose o...
Status
Terminated
Location
Novartis
Start Date
2008-03
Trial ID
NCT00658333
This study will examine the safety and effectiveness of an experimental dru...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2000-12
Trial ID
NCT00007163
Treatments Being Tested
The purpose of this research study is to see if a study drug called Tociliz...
Status
Completed
Location
Cedars Sinai Medical Center (CACS)
Start Date
2018-12-20
Trial ID
NCT03644667
Treatments Being Tested
Current strategies for the medical management of transplant patients are la...
Status
Completed
Location
Transplantation Surgery, Karolinska University Hospital
Start Date
2005-11
Trial ID
NCT00255593
Treatments Being Tested
Primary Objective: The primary objective of this study is to assess the to...
Status
Terminated
Location
CHU Hôpital Sud
Start Date
2020-02-11
Trial ID
NCT04107675
Treatments Being Tested
The study was a Phase III, double-blind, placebo-controlled, randomized stu...
Status
Completed
Location
Investigator Site
Start Date
2015-11
Trial ID
NCT02553317
Treatments Being Tested